Clinical characteristics, diagnosis, and management outcome of surfactant deficiency respiratory distress syndrome in term and near-term neonates. A retrospective observational study

Acta Biomed. 2022 Dec 16;93(6):e2022337. doi: 10.23750/abm.v93i6.13794.

Abstract

Aim: This study aims to describe the clinical characteristics of SRDS in term and late preterm neonates.

Methods: This is an observation retrospective chart review of full-term and late preterm neonates born older than 35 to 41 weeks gestation age diagnosed with SRDS. The diagnosis was based on clinical & radiological manifestations of SRDS.

Results: 1547 neonates were admitted during this period to NICU with a diagnosis of increased work of breathing for further management. 117 cases of term and near-term neonates (mean GA = 36.8 wks) had a confirmed diagnosis of Surfactant deficiency SRDS. Who compared 60 preterm neonates with SRDS less than 35 weeks gestation (mean GA 27.5 wks) as a control. The mean birth weight was 2.8 kg vs 1.1 kg in the preterm group. SRDS occurs more among the male gender (58%), with CS in 78.6 % of all diagnosed cases. No apparent cause was found in 28.2 %, while 37.6% of all cases were born to mothers with diabetes mellitus, and 27% were born to mothers with either GBs infection, maternal chorioamnionitis, or prolonged rupture of the membrane.

Conclusion: SRDS is not uncommon among full-term and near-term neonates (10/1000 live birth). By far, the most common associated risk factors are maternal diabetes mellitus and cesarean section. It affects males more than females. Most cases will run a mild-to-moderate course that responds to non-invasive ventilation.

Publication types

  • Observational Study

MeSH terms

  • Cesarean Section*
  • Female
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Male
  • Pregnancy
  • Respiratory Distress Syndrome, Newborn* / diagnosis
  • Respiratory Distress Syndrome, Newborn* / etiology
  • Respiratory Distress Syndrome, Newborn* / therapy
  • Retrospective Studies
  • Surface-Active Agents

Substances

  • Surface-Active Agents